Botulinum toxin A (Helse Stavanger)

A型肉毒毒素（Helse Stavanger）

Report date: 2022/09/14 16:39:56

Base Information

Drug NameBotulinum toxin A (Helse Stavanger)

Drug Alias NameN/A

ClassificationNatural product/Extract > Microbial extractBiologics > Protein drugs > Toxin

Mechanisms of ActionSynaptosomal-associated protein 25 inhibitors

TargetsSynaptosomal-associated protein 25

Therapy Area/IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, Major

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesHelse Stavanger Hf

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, Major

ATC CodeN/A